Satellos Chief Scientific Officer Dr. Phil Lambert joined host Jim Cornall on the Base to Base Biotech podcast to discuss the company’s groundbreaking approach to muscle regeneration for Duchenne muscular dystrophy. Dr. Lambert shared insights into the science behind Satellos’ lead candidate, their unique strategy for drugging satellite cells, and the promising clinical data recently presented at MDA 2025.
Listen to the episode here.
